SEC Form 4 · accession 0001493152-26-040736
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth Lederman
Officer — Chief Executive Officer · Director
Period of report
Aug 27, 2026
Accepted (ET)
Aug 31, 2026 · 8:00 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Aug 27, 2026 | P | 2,000 | $13.79 | A | 11,005 | I | By IRA Account |
| Common Stock, $0.001 par value | holding | — | — | — | 20,001 | D | ||
| Common Stock, $0.001 par valueF1 | holding | — | — | — | 1 | I | Lederman & Co. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person may be deemed a control person of this entity.